Xin Lang Cai Jing·2025-08-27 01:32Group 1 - The core viewpoint of the news highlights the trading performance and financing activities of Spring Medical, indicating a slight decline in stock price and notable financing activities on August 26 [1] - On August 26, Spring Medical's stock price decreased by 0.70%, with a trading volume of 51.21 million yuan, and a net financing purchase of 2.68 million yuan [1] - As of August 26, the total balance of margin trading for Spring Medical was 43.59 million yuan, which accounts for 0.67% of its market capitalization, indicating a high level compared to the past year [1] Group 2 - Spring Medical, established on February 12, 1998, specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products being joint prosthetics and spinal implants [2] - The company reported a revenue of 230 million yuan for the first quarter of 2025, reflecting a year-on-year growth of 3.60%, and a net profit attributable to shareholders of 58.07 million yuan, up by 5.20% [2] - The company has distributed a total of 359 million yuan in dividends since its A-share listing, with 309 million yuan distributed over the past three years [3] Group 3 - As of March 31, 2025, the number of shareholders for Spring Medical increased by 7.48% to 7,182, while the average circulating shares per person decreased by 6.99% to 11,063 shares [2] - Among the top ten circulating shareholders, Zhonggeng Small Cap Value Stock holds 2.87 million shares, remaining unchanged, while Hong Kong Central Clearing Limited increased its holdings by 1.11 million shares to 2.29 million shares [3] - New shareholders include Ping An Low Carbon Economy Mixed A, which holds 1 million shares, while some funds exited the top ten circulating shareholders list [3]